Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies ...

Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...

The appointment of Dr. Banerjee culminates Artiva’s efforts to build a seasoned development team with strong expertise in autoimmunity and cell therapy that includes the following recent additions: ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

In this interview, Chiara Nozzoli, speaks on her career journey and her work in haematopoietic stem cell transplantation, ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

The "Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035, by Type of Therapy Packed, Package Engineering Design, Scale of Operation and Key Geographical Regions" report has been ...

Senti Biosciences, Inc.’s SNTI share price has surged by 8.41%, which has investors questioning if this is right time to sell ...

To stay up to date on Senti Bio’s recent developments on the Webull Corporate Connect Services Platform, current Webull users can follow SNTI from the app on their smartphone or table device. To ...

NKGen Biotech (NKGN) announced the oral presentation of updated Phase 1 clinical data from the Phase 1/2a trial evaluating troculeucel, ...

Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 32.38%, which has investors questioning if this is right time ...

New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...